Kazia Therapeutics (KZIA) Shares Outstanding (2018 - 2025)

Kazia Therapeutics' Shares Outstanding history spans 5 years, with the latest figure at $518.4 million for Q2 2025.

  • For Q2 2025, Shares Outstanding rose 136.32% year-over-year to $518.4 million; the TTM value through Jun 2025 reached $518.4 million, up 136.32%, while the annual FY2025 figure was $518.4 million, 136.32% up from the prior year.
  • Shares Outstanding reached $518.4 million in Q2 2025 per KZIA's latest filing, up from $219.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $518.4 million in Q2 2025 to a low of $99.4 million in Q2 2022.
  • Average Shares Outstanding over 4 years is $247.4 million, with a median of $185.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: skyrocketed 43.93% in 2024, then skyrocketed 136.32% in 2025.
  • A 4-year view of Shares Outstanding shows it stood at $99.4 million in 2022, then skyrocketed by 53.35% to $152.4 million in 2023, then soared by 43.93% to $219.4 million in 2024, then surged by 136.32% to $518.4 million in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Shares Outstanding are $518.4 million (Q2 2025), $219.4 million (Q2 2024), and $152.4 million (Q2 2023).